Sponsor Pipeline

NEOK Bio, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07612176 A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants… Locally Advanced (Unresectable) or Metastatic Solid Tumors Recruiting
NCT07612189 A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With… Locally Advanced (Unresectable) or Metastatic Solid Tumors Recruiting
Get alerts when NEOK Bio, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free